Where are you?
To give you the most accurate information about our products and what we can do for you, we need to direct you to the right site.
To give you the most accurate information about our products and what we can do for you, we need to direct you to the right site.
Adhoc Press Release
Kuros reports Corporate Highlights as of Q1 2024 including increase in direct MagnetOsTM sales
Adhoc Press Release
Kuros reports 163% growth in direct MagnetOs sales and 153% increase in total medical device sales for the full year 2023
Adhoc Press Release
Kuros Biosciences Announces Results from Two Prospective Randomized Clinical Trials: STRUCTURE and MAXA
Adhoc Press Release
Kuros reports a 150% increase in direct MagnetOs sales in the first nine months of 2023 and announces changes within the Executive Management
Adhoc Press Release
Kuros Biosciences Reports Results for First Half 2023
Adhoc Press Release
Annual General Meeting of Kuros Biosciences approves all resolutions